These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34427289)

  • 21. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome.
    Woo HY; Kim KH; Rhee EJ; Park H; Lee MK
    Endocr J; 2012; 59(9):781-90. PubMed ID: 22673409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
    Vosnakis C; Georgopoulos NA; Rousso D; Mavromatidis G; Katsikis I; Roupas ND; Mamali I; Panidis D
    Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome.
    Adamska A; Karczewska-Kupczewska M; Lebkowska A; Milewski R; Górska M; Otziomek E; Nikolajuk A; Wolczynski S; Kowalska I
    Endocr J; 2016 Dec; 63(12):1107-1112. PubMed ID: 27616010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationships of irisin with bone mineral density and body composition in PCOS patients.
    Gao S; Cheng Y; Zhao L; Chen Y; Liu Y
    Diabetes Metab Res Rev; 2016 May; 32(4):421-8. PubMed ID: 26589554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum myonectin and irisin levels with myonectin and FNDC5 expressions in polycystic ovary syndrome: a case control study.
    Onat T; Inandiklioglu N; Kara M; Serdar Yalvac E; Turkler C; Ciplak B; Altindag MM
    J Obstet Gynaecol; 2022 Jul; 42(5):1381-1387. PubMed ID: 34907845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls.
    Lass N; Kleber M; Winkel K; Wunsch R; Reinehr T
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3533-40. PubMed ID: 21880803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome.
    Yetim Şahin A; Baş F; Yetim Ç; Uçar A; Poyrazoğlu Ş; Bundak R; Darendeliler F
    Turk J Med Sci; 2019 Aug; 49(4):1117-1125. PubMed ID: 31286756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles.
    Bousmpoula A; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Chasiakou S; Kouskouni E; Baka S
    Gynecol Endocrinol; 2019 Sep; 35(9):803-806. PubMed ID: 30982370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bariatric Surgery Reduces Serum Anti-mullerian Hormone Levels in Obese Women With and Without Polycystic Ovarian Syndrome.
    Chiofalo F; Ciuoli C; Formichi C; Selmi F; Forleo R; Neri O; Vuolo G; Paffetti P; Pacini F
    Obes Surg; 2017 Jul; 27(7):1750-1754. PubMed ID: 28378209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism.
    Park AS; Lawson MA; Chuan SS; Oberfield SE; Hoeger KM; Witchel SF; Chang RJ
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1786-92. PubMed ID: 20150576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome.
    Caanen MR; Peters HE; van de Ven PM; Jüttner AMFM; Laven JSE; van Hooff MHA; Lambalk CB
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1084-e1095. PubMed ID: 33351079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
    Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of weight loss program on serum anti-Müllerian hormone level in obese and overweight infertile women with polycystic ovary syndrome.
    Moini A; Arabipoor A; Hemat M; Ahmadi J; Salman-Yazdi R; Zolfaghari Z
    Gynecol Endocrinol; 2019 Feb; 35(2):119-123. PubMed ID: 30580636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
    Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
    J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free androgen index and Irisin in polycystic ovary syndrome.
    Li H; Xu X; Wang X; Liao X; Li L; Yang G; Gao L
    J Endocrinol Invest; 2016 May; 39(5):549-56. PubMed ID: 26584566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Müllerian Hormone in Girls with Premature Adrenarche: The Impact of Polycystic Ovary Syndrome History in their Mothers.
    Efthymiadou A; Bogiatzidou M; Kritikou D; Chrysis D
    J Pediatr; 2019 Feb; 205():190-194. PubMed ID: 30529136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.